Ultragenyx Pharmaceutical
RARE
#3251
Rank
C$5.03 B
Marketcap
$52.11
Share price
-4.26%
Change (1 day)
-17.95%
Change (1 year)

EPS for Ultragenyx Pharmaceutical (RARE)

EPS in 2023 (TTM): -$13.85

According to Ultragenyx Pharmaceutical's latest financial reports the company's current EPS (TTM) is -$14.74. In 2022 the company made an earnings per share (EPS) of -$14.55 a decrease over its 2021 EPS that were of -$9.66.

EPS history for Ultragenyx Pharmaceutical from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$13.85-4.81%
2022-$14.5550.67%
2021-$9.66113.69%
2020-$4.52-55.9%
2019-$10.2582.56%
2018-$5.61-45.15%
2017-$10.2314.68%
2016-$8.9257.36%
2015-$5.6769.83%
2014-$3.3415.22%
2013-$2.90

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.12-107.60%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.92-93.75%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.06-72.46%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.98-93.36%๐Ÿ‡บ๐Ÿ‡ธ USA